Alkermes, Inc.
-
Ticker
ALKS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Dublin, Ireland
Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders.
REPORT RATINGS
4.8 / 5.0 (80)
Alkermes, Inc. reports have an aggregate usefulness score of 4.8 based on 80 reviews.
Alkermes, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Corporate Responsibility Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Alkermes, Inc. Sustainability Report, Alkermes, Inc. Corporate Social Responsibility Report, Alkermes, Inc. CSR Report, Alkermes, Inc. Corporate Responsibility, Alkermes, Inc. CR Report, Alkermes, Inc. Citizenship Report, Alkermes, Inc. ESG Report, and Alkermes, Inc. Environmental Report online.